Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05694338 · ClinicalTrials.gov registry record
Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery
A clinical trial of Gastrointestinal Cancer, sponsored by The Guthrie Clinic.
- Active
- Registry status
- 100
- Enrollment target
- 2
- Study locations
NCT05694338: Active study of Gastrointestinal Cancer, sponsored by The Guthrie Clinic.
NCT05694338 is a study of Gastrointestinal Cancer that is active but no longer recruiting, run by The Guthrie Clinic. The registered enrollment target is 100 participants, below the 228-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05694338, a study of Gastrointestinal Cancer, is active but no longer recruiting, sponsored by The Guthrie Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research is for patients who have gastrointestinal cancer and have a planned major surgery. The purpose of this research is to identify cancer patients who may be at risk for frailty. Frailty is common in older adults and may include symptoms of weight loss, weakness, fatigue, low activity, slow walking and other illnesses. Frailty may increase the risk of problems after major surgery. The study will involve a survey, a blood sample, and a review of medical records.
Primary Outcome
Assess Clinical Risk Analysis Index (RAI-C) Scores in rural patients referred for major abdominal surgeries. Survey values will be added to yield a final RAI-C score between 0 and 81. Percent of patients considered frail will be defined as Clinical Risk Analysis Index (RAI-C) Scores of 21 or higher
Conditions Studied
Interventions
- OTHER Frailty survey
Study Locations (2)
New York
- Guthrie Medical Group - East Corning
Pennsylvania
- Robert Packer Hospital - Sayre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2027-06-01 |
What the registry record for NCT05694338 still lists
NCT05694338 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 228-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Frailty survey is the first listed.
NCT05694338 reports a single indexed study location in New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05694338 about?
NCT05694338 is a clinical study titled "Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery". This research is for patients who have gastrointestinal cancer and have a planned major surgery. The purpose of this research is to identify cancer patients who may be at risk for frailty. Frailty is common in older adults and may include symptoms of weight loss, weakness, fatigue, low activity, slo...
What is the current status of trial NCT05694338?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2023-03-13. Estimated completion is 2027-06-01.
What conditions does trial NCT05694338 study?
This clinical trial studies the following conditions: Gastrointestinal Cancer.
What interventions are being tested in trial NCT05694338?
The interventions under investigation include: Frailty survey (OTHER).
Who is sponsoring clinical trial NCT05694338?
This trial is sponsored by The Guthrie Clinic, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05694338 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05694338's enrollment target sits among peer trials
100 28th of 49 higher than 18 of 49 other Gastrointestinal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastrointestinal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Improving Comprehensive Care of Cancer Patients
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI